Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Capital Reinvestment Ratio
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd capital reinvestment ratio. Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (600332) has a Capital Reinvestment Ratio of 0.18x as of December 2025, meaning it reinvests 0% of its operating cash flow (CN¥1.84 Billion) in capital expenditures (CN¥330.65 Million). Check 600332 capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (2000–2025)
Capital reinvestment ratio of Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd from 2000 to 2025. This chart tracks Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd's Capital Reinvestment Ratio across 24 annual periods. Also explore Guangzhou Baiyunshan Pharmaceutical Hold net asset momentum to track the company's year-over-year net asset growth rate.
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Capital Reinvestment Ratio by Year (2000–2025)
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd capital reinvestment ratio by year from 2000 to 2025. For the full cash flow conversion analysis, see 600332 operating cash flow.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 4.76x | CN¥260.23 Million | CN¥1.24 Billion | ▲ +1353.9% |
| 2024 | 0.33x | CN¥3.44 Billion | CN¥1.13 Billion | ▼ -17.4% |
| 2023 | 0.40x | CN¥4.10 Billion | CN¥1.63 Billion | ▲ +100.7% |
| 2022 | 0.20x | CN¥7.00 Billion | CN¥1.38 Billion | ▼ -10.6% |
| 2021 | 0.22x | CN¥5.67 Billion | CN¥1.25 Billion | ▼ -85.2% |
| 2020 | 1.50x | CN¥585.19 Million | CN¥876.50 Million | ▲ +213.5% |
| 2019 | 0.48x | CN¥5.02 Billion | CN¥2.40 Billion | ▲ +420.8% |
| 2018 | 0.09x | CN¥5.22 Billion | CN¥478.62 Million | ▼ -14.5% |
| 2017 | 0.11x | CN¥1.83 Billion | CN¥196.77 Million | ▲ +15.0% |
| 2016 | 0.09x | CN¥2.44 Billion | CN¥228.03 Million | ▼ -64.9% |
| 2015 | 0.27x | CN¥1.94 Billion | CN¥515.34 Million | ▲ +32.2% |
| 2014 | 0.20x | CN¥1.76 Billion | CN¥353.65 Million | ▼ -23.3% |
| 2013 | 0.26x | CN¥1.34 Billion | CN¥350.35 Million | ▲ +151.9% |
| 2012 | 0.10x | CN¥506.53 Million | CN¥52.61 Million | ▼ -90.9% |
| 2010 | 1.14x | CN¥73.17 Million | CN¥83.20 Million | ▲ +470.6% |
| 2009 | 0.20x | CN¥439.39 Million | CN¥87.56 Million | ▼ -99.0% |
| 2008 | 20.80x | CN¥6.10 Million | CN¥126.98 Million | ▲ +6271.7% |
| 2007 | 0.33x | CN¥375.74 Million | CN¥122.69 Million | ▼ -86.0% |
| 2006 | 2.33x | CN¥38.88 Million | CN¥90.45 Million | ▲ +173.7% |
| 2005 | 0.85x | CN¥146.32 Million | CN¥124.36 Million | ▼ -44.8% |
| 2004 | 1.54x | CN¥200.54 Million | CN¥308.69 Million | ▲ +49.8% |
| 2002 | 1.03x | CN¥169.01 Million | CN¥173.70 Million | ▼ -10.2% |
| 2001 | 1.14x | CN¥140.15 Million | CN¥160.44 Million | ▲ +100.9% |
| 2000 | 0.57x | CN¥286.95 Million | CN¥163.53 Million | — |